(DBEF) Xtrackers MSCI EAFE Hedged - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US2330512003

DBEF: Equity, Developed Market, Hedged, Foreign, Index-Based

The Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) is a passively managed fund that tracks the MSCI EAFE Hedged Index, providing investors with exposure to developed international markets while minimizing the impact of currency fluctuations between the US dollar and the currencies of the constituent countries.

By investing at least 80% of its assets in the component securities of the underlying index, DBEF offers a diversified portfolio of international stocks, albeit with a non-diversified structure. As a Foreign Large Blend ETF, it is designed to capture the performance of large-cap stocks in developed markets outside the US, making it an attractive option for investors seeking international diversification.

Analyzing the funds technical data, we observe a bullish trend, with the last price of $45.46 exceeding the 20-day Simple Moving Average (SMA) of $44.86, indicating a potential upward momentum. The 50-day SMA ($43.10) and 200-day SMA ($42.44) are also trending upwards, suggesting a longer-term positive outlook. With an Average True Range (ATR) of 0.43, representing a 0.94% daily price movement, the funds volatility is relatively moderate.

From a fundamental perspective, DBEFs Assets Under Management (AUM) stand at $8.03 billion, indicating a sizable presence in the market. Considering the current technical and fundamental data, our forecast suggests that DBEF is poised for continued growth, driven by the upward trend in its technical indicators and the substantial AUM. We anticipate that the fund will continue to track the performance of the underlying index, potentially reaching new 52-week highs in the coming months, driven by the ongoing recovery in international developed markets.

Based on our analysis, investors may consider accumulating DBEF as a strategic play to diversify their portfolios and capitalize on the potential for long-term growth in international developed markets, while minimizing currency risks.

Additional Sources for DBEF ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

DBEF ETF Overview

Market Cap in USD 8,002m
Category Foreign Large Blend
TER 0.36%
IPO / Inception 2011-06-09

DBEF ETF Ratings

Growth Rating 81.1
Fundamental -
Dividend Rating 4.25
Rel. Strength -4.31
Analysts -
Fair Price Momentum 43.42 USD
Fair Price DCF -

DBEF Dividends

Dividend Yield 12m 0.70%
Yield on Cost 5y 1.29%
Annual Growth 5y -8.05%
Payout Consistency 65.0%
Payout Ratio %

DBEF Growth Ratios

Growth Correlation 3m 84.7%
Growth Correlation 12m 71.1%
Growth Correlation 5y 93.9%
CAGR 5y 13.80%
CAGR/Max DD 5y 0.92
Sharpe Ratio 12m 1.31
Alpha -0.51
Beta 0.716
Volatility 12.07%
Current Volume 1570.6k
Average Volume 20d 525.3k
What is the price of DBEF shares?
As of June 29, 2025, the stock is trading at USD 44.00 with a total of 1,570,634 shares traded.
Over the past week, the price has changed by +2.18%, over one month by +0.26%, over three months by +3.08% and over the past year by +10.67%.
Is Xtrackers MSCI EAFE Hedged a good stock to buy?
Yes. Based on ValueRay´s Analyses, Xtrackers MSCI EAFE Hedged (NYSE ARCA:DBEF) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 81.13 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBEF is around 43.42 USD . This means that DBEF is currently overvalued and has a potential downside of -1.32%.
Is DBEF a buy, sell or hold?
Xtrackers MSCI EAFE Hedged has no consensus analysts rating.
What are the forecasts for DBEF share price target?
According to our own proprietary Forecast Model, DBEF Xtrackers MSCI EAFE Hedged will be worth about 49.5 in June 2026. The stock is currently trading at 44.00. This means that the stock has a potential upside of +12.48%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 49.5 12.5%